Carbon Impact Report Shows Growing Lab Commitment to Reducing Carbon Emissions
Life sciences and clinical laboratories are accelerating zero-carbon goals, says My Green Lab CEO
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
Life sciences and clinical laboratories are accelerating zero-carbon goals, says My Green Lab CEO
The momentum for targeted therapies has downstream implications for clinical laboratories
Roche acquires a workflow rather than a company, says AI industry observer
Labcorp’s new genotyping test can identify gene variants that may make standard oncologic treatment deadly for some
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
The company’s patients can use AI to look at trends going back five years
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
By partnering with Hims & Hers and Epic, GRAIL bypasses traditional lab test arrangement
Consortium hosts large proteomics dataset for neurodegenerative diseases
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers